Tag: BreathActuated

Posted on

First Breath-Actuated, Dry-Powder Inhaler for Acute Asthma Approved – Monthly Prescribing Reference


Monthly Prescribing Reference

First Breath-Actuated, Dry-Powder Inhaler for Acute Asthma Approved
Monthly Prescribing Reference
Teva announced that the Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol sulfate inhalation powder), the first breath-actuated dry-powder inhaler approved for acute asthma symptoms. ProAir RespiClick is indicated for the …
FDA clears Teva asthma med (TEVA)Seeking Alpha (registration)
FDA Approves Teva's New Asthma TreatmentArutz Sheva
FDA approves ProAir RespiClick for treatment of acute asthma symptomsHealio
PharmiWeb.com (press release)
all 10 news articles »

View full post on asthma – Google News

Posted on

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 5-11 Years Old With Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Beclomethasone dipropionate;   Drug: Placebo;   Drug: albuterol/salbutamol 90 mcg
Sponsors:   Teva Pharmaceutical Industries;   Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified January 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Posted on

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Beclomethasone dipropionate;   Drug: Placebo;   Drug: Albuterol/salbutamol
Sponsors:   Teva Pharmaceutical Industries;   Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified January 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days